Haleon (HLN) EBT Margin (2021 - 2023)
Haleon (HLN) posted EBT Margin of 17.06% for Q4 2023, up 12.3% on a QoQ basis from 15.19% in Q2 2023, and down 3467.0% year-over-year from 0.51% in Q4 2022.
Haleon (HLN) EBT Margin (2021 - 2023) Analysis & Trends
Haleon's EBT Margin history runs 3 years deep, the most recent figure standing at 17.06% for Q4 2023.
- Quarterly EBT Margin fell 3467.0% year-over-year to 17.06% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 22.08% (changed N/A YoY) and the FY2025 annual result came in at 19.51%, up 251.0% from the prior year.
- EBT Margin was 17.06% for Q4 2023 at Haleon, up from 15.19% in the prior quarter.
- Across five years, EBT Margin topped out at 51.73% in Q4 2022 and bottomed at 15.19% in Q2 2023.
- A 3-year average of 23.94% and a median of 17.59% in 2021 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin jumped 3414 bps — and 2023, when it slumped 3467 bps.
- Haleon's EBT Margin stood at 17.59% in 2021, then surged by 194 bps to 51.73% in 2022, then plunged by 67 bps to 17.06% in 2023.
- Business Quant data shows HLN's EBT Margin at 17.06% in Q4 2023, 15.19% in Q2 2023, and 18.15% in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 40.73% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 6.35% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -3.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 17.06% |
| Jun 30, 2023 | 15.19% |
| May 3, 2023 | 18.15% |
| Dec 31, 2022 | 51.73% |
| Dec 31, 2021 | 17.59% |